Daclatasvir Dihydrochloride CAS 1009119-65-6 Purity >99.0% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Daclatasvir Dihydrochloride (CAS: 1009119-65-6) with high quality. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Daclatasvir Dihydrochloride, Please contact: alvin@ruifuchem.com
| Chemical Name | Daclatasvir Dihydrochloride |
| Synonyms | Daclatasvir DiHCl; BMS-790052 Dihydrochloride; BMS 790052 (Di HCl Salt); EBP 883 Dihydrochloride; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-Imidazole-5,2-diyl-(2S)-2,1-Pyrrolidinediyl[(1S)-1-(1-Methylethyl)-2-oxo-2,1-Ethanediyl]]]biscarbamic Acid Dimethyl Ester Hydrochloride |
| Stock Status | In Stock, 300/Kilograms per Month |
| CAS Number | 1009119-65-6 |
| Molecular Formula | C40H51ClN8O6 |
| Molecular Weight | 775.35 g/mol |
| Melting Point | >207℃(dec.) |
| COA & MSDS | Available |
| Origin | Shanghai, China |
| Category | API (Active Pharmaceutical Ingredient) |
| Brand | Ruifu Chemical |
| Items | Specifications | Results |
| Appearance | Off-White to Light Yellow Powder |
Complies |
| Water by Karl Fischer | <0.50% | 0.37% |
| Residue on Ignition | <0.20% | 0.09% |
| Single Impurity | <0.20% | 0.08% |
| Total Impurities | <1.00% | 0.31% |
| Heavy Metals | ≤20ppm | <20ppm |
| Purity / Analysis Method | >99.0% (HPLC) | 99.69% |
| Infrared Spectrum | Consistent with Structure | Complies |
| 1H NMR Spectrum | Consistent with Structure | Complies |
| Conclusion | The product has been tested and complies with the given specifications | |
| Shelf Life | 24 Months if Stored Properly | |
Package: Bottle, 1kg / 5kg / Aluminium tin, 25kg / Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry (2~8℃) and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Daclatasvir Dihydrochloride (CAS: 1009119-65-6) is a hepatitis C virus nonstructural 5A (NS5A) replication complex inhibitor which was first approved in Japan for the treatment of genotype 1 HCV patients who fail to respond to interferon plus ribavirin. The drug has also been approved for patients with untreated, chronic HCV who are eligible for interferon. Additionally, in Europe, daclatasvir was approved for use in combination with other products across genotype 1-4 HCV.
Daclatasvir Dihydrochloride is the dihydrochloride salt form of Daclatasvir, an orally available inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex, with potential activity against HCV. Daclatasvir is used with another antiviral medication (Sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. Daclatasvir should never be used without Sofosbuvir. Daclatasvir and Sofosbuvir may also be used with another antiviral medication (Ribavirin).
